Show simple item record

dc.contributor.authorDunne, JL
dc.contributor.authorRichardson, SJ
dc.contributor.authorAtkinson, MA
dc.contributor.authorCraig, ME
dc.contributor.authorDahl-Jørgensen, K
dc.contributor.authorFlodström-Tullberg, M
dc.contributor.authorHyöty, H
dc.contributor.authorInsel, RA
dc.contributor.authorLernmark, Å
dc.contributor.authorLloyd, RE
dc.contributor.authorMorgan, NG
dc.contributor.authorPugliese, A
dc.date.accessioned2019-05-17T09:59:18Z
dc.date.issued2019-05-01
dc.description.abstractIn type 1 diabetes, pancreatic beta cells are destroyed by chronic autoimmune responses. The disease develops in genetically susceptible individuals, but a role for environmental factors has been postulated. Viral infections have long been considered as candidates for environmental triggers but, given the lack of evidence for an acute, widespread, cytopathic effect in the pancreas in type 1 diabetes or for a closely related temporal association of diabetes onset with such infections, a role for viruses in type 1 diabetes remains unproven. Moreover, viruses have rarely been isolated from the pancreas of individuals with type 1 diabetes, mainly (but not solely) due to the inaccessibility of the organ. Here, we review past and recent literature to evaluate the proposals that chronic, recurrent and, possibly, persistent enteroviral infections occur in pancreatic beta cells in type 1 diabetes. We also explore whether these infections may be sustained by different virus strains over time and whether multiple viral hits can occur during the natural history of type 1 diabetes. We emphasise that only a minority of beta cells appear to be infected at any given time and that enteroviruses may become replication defective, which could explain why they have been isolated from the pancreas only rarely. We argue that enteroviral infection of beta cells largely depends on the host innate and adaptive immune responses, including innate responses mounted by beta cells. Thus, we propose that viruses could play a role in type 1 diabetes on multiple levels, including in the triggering and chronic stimulation of autoimmunity and in the generation of inflammation and the promotion of beta cell dysfunction and stress, each of which might then contribute to autoimmunity, as part of a vicious circle. We conclude that studies into the effects of vaccinations and/or antiviral drugs (some of which are currently on-going) is the only means by which the role of viruses in type 1 diabetes can be finally proven or disproven.en_GB
dc.description.sponsorshipSouth-Eastern Norway Regional Health Authorityen_GB
dc.description.sponsorshipNovo Nordisk Foundationen_GB
dc.description.sponsorshipSwedish Child Diabetes Foundationen_GB
dc.description.sponsorshipSwedish Research Councilen_GB
dc.description.sponsorshipPEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Programmeen_GB
dc.description.sponsorshipnPOD Virus Groupen_GB
dc.description.sponsorshipJDRF-CDAen_GB
dc.description.sponsorshipMRCen_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.identifier.citationVol. 62, issue 5 pp. 744 - 753en_GB
dc.identifier.doi10.1007/s00125-019-4811-7
dc.identifier.grantnumberJDRF 3-SRA-2017-492-A-Nen_GB
dc.identifier.grantnumber5-CDA-2014-221-A-Nen_GB
dc.identifier.grantnumberMR/P010695/1en_GB
dc.identifier.grantnumber15/0005364en_GB
dc.identifier.grantnumberFP7/2007–2013en_GB
dc.identifier.urihttp://hdl.handle.net/10871/37128
dc.language.isoenen_GB
dc.publisherSpringer Natureen_GB
dc.rights© The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_GB
dc.subjectAntiviral therapyen_GB
dc.subjectAutoimmunityen_GB
dc.subjectBeta cellsen_GB
dc.subjectEnterovirusen_GB
dc.subjectPancreasen_GB
dc.subjectPreventionen_GB
dc.subjectType 1 diabetesen_GB
dc.subjectVaccineen_GB
dc.subjectVirusen_GB
dc.titleRationale for enteroviral vaccination and antiviral therapies in human type 1 diabetesen_GB
dc.typeArticleen_GB
dc.date.available2019-05-17T09:59:18Z
dc.identifier.issn0012-186X
dc.descriptionThis is the final version. Available from Springer Verlag via the DOI in this record.en_GB
dc.identifier.journalDiabetologiaen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2018-12-11
exeter.funder::Juvenile Diabetes Research Foundation Internationalen_GB
exeter.funder::Juvenile Diabetes Research Foundation Internationalen_GB
exeter.funder::Medical Research Council (MRC)en_GB
exeter.funder::Juvenile Diabetes Research Foundation Internationalen_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2019-05-01
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-05-17T09:22:37Z
refterms.versionFCDVoR
refterms.dateFOA2019-05-17T09:59:21Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2019
Open Access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Except where otherwise noted, this item's licence is described as © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.